Pharmacology - Mock Test 17

Question 161

Hyperprolactinemia can cause the following except

A) Amenorrhoea B) Gynaecomastia C) Multiple ovulation D) Depressed fertility

---

No Details

Question 162

For therapeutic use, growth hormone is obtained from

A) Recombinant DNA technique B) Human cadaver pituitaries C) Porcine pituitaries D) Chemical synthesis

---

No Details

Question 163

Drugs that suppress growth hormone release in acromegaly include the following<u> except</u>

A) Bromocriptine B) Somatostatin C) Octreotide D) Nafarelin

---

No Details

Question 164

Indications of somatostatin include

A) Macroprolactinoma B) Zollinger Ellison syndrome C) Bleeding esophageal varices D) Steatorrhoea

---

No Details

Question 165

Somatostatin inhibits the release of

A) Growth hormone B) Insulin C) Thyrotropin D) All of the above

---

No Details

Question 166

Octreotide is a long acting synthetic analogue of

A) Prolactin B) Growth hormone C) Somatostatin D) Gonadotropin releasing hormone

---

No Details

Question 167

Several actions of growth hormone are exerted through the elaboration of

A) Cyclic AMP B) Cyclic GMP C) Somatostatin D) Insulin like growth factor-1

---

No Details

Question 168

Actions of growth hormone include the following <u>except</u>

A) Increased protein synthesis B) Increased fat utilization C) Increased carbohydrate utilization D) Glucose intolerance

---

No Details

Question 169

Which hormone acts through a cytoplasmic receptor

A) Calcitriol B) Prolactin C) Vasopressin D) None of the above

---

No Details

Question 170

The following hypothalamic regulatory hormone is not a peptide

A) Growth hormone release inhibitory hormone B) Prolactin release inhibitory hormone C) Gonadotropin releasing hormone D) Corticotropin releasing hormone

---

No Details